Data gathered: May 17
Alternative Data for Vericel
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 14 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 13,000 | Sign up | Sign up | Sign up |
| Employee Rating | 68 | Sign up | Sign up | Sign up |
| Google Trends | 4 | Sign up | Sign up | Sign up |
| Patents | 4 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | N/A | Sign up | Sign up | Sign up |
| Facebook Followers | 462 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 8,261 | Sign up | Sign up | Sign up |
| Twitter Followers | 879 | Sign up | Sign up | Sign up |
| Twitter Mentions | 44 | Sign up | Sign up | Sign up |
| News Mentions | 1 | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 54 | Sign up | Sign up | Sign up |
| Linkedin Employees | 349 | Sign up | Sign up | Sign up |
About Vericel
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States.
| Price | $47.61 |
| Target Price | Sign up |
| Volume | 371,610 |
| Market Cap | $2.4B |
| Year Range | $30.85 - $52.9 |
| Dividend Yield | 0% |
| PE Ratio | 4941 |
| Revenue per Employee | $681,246 |
| Industry | Biotechnology |
In the news
 |
Russell Investments Group Ltd. Sells 3,934 Shares of Vericel Co. (NASDAQ:VCEL)May 16 - ETF Daily News |
|
Vericel Co. Expected to Earn Q2 2024 Earnings of ($0.08) Per Share (NASDAQ:VCEL)May 14 - ETF Daily News |
 |
Vericel (NASDAQ:VCEL) Rating Lowered to Sell at StockNews.comMay 14 - ETF Daily News |
|
Vericel (NASDAQ:VCEL) Price Target Raised to $55.00May 12 - ETF Daily News |
|
Vericel Co. to Post Q1 2025 Earnings of $0.04 Per Share, HC Wainwright Forecasts (NASDAQ:VCEL)May 11 - ETF Daily News |
|
Leerink Partnrs Weighs in on Vericel Co.’s Q1 2025 Earnings (NASDAQ:VCEL)May 11 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '24 | 51M | 16M | 35M | -3.9M | -5.5M | -0.080 |
| Q4 '23 | 65M | 16M | 49M | 13M | 14M | 0.260 |
| Q3 '23 | 46M | 15M | 31M | -3.7M | -2.6M | -0.080 |
| Q2 '23 | 46M | 16M | 30M | -5M | -4.9M | -0.110 |
| Q1 '23 | 41M | 14M | 27M | -7.5M | -7.4M | -0.160 |
Insider Transactions View All
| Colangelo Dominick filed to sell 195,307 shares at $44.6. April 19 '24 |
| ZERBE ROBERT L MD filed to sell 23,395 shares at $51.6. March 29 '24 |
| Colangelo Dominick filed to sell 194,870 shares at $44. March 15 '24 |
| Halpin Michael filed to sell 949 shares at $44.7. March 13 '24 |
| Flynn Sean C. filed to sell 167 shares at $45.3. March 11 '24 |
Similar companies
Read more about Vericel (VCEL) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Vericel?
The Market Cap of Vericel is $2.4B.
What is Vericel's PE Ratio?
As of today, Vericel's PE (Price to Earnings) ratio is 4941.
How Many People Work at Vericel?
As of our latest update, Vericel employed approximately 305 people worldwide. However, it's important to note that Vericel's workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.
What is Vericel's revenue per employee?
$681,246. To calculate Vericel's revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.
What is the current stock price of Vericel?
Currently, the price of one share of Vericel stock is $47.61.
How can I analyze the VCEL stock price chart for investment decisions?
The VCEL stock price chart above provides a comprehensive visual representation of Vericel's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Vericel shares. Our platform offers an up-to-date VCEL stock price chart, along with technical data analysis and alternative data insights.
Does VCEL offer dividends to its shareholders?
As of our latest update, Vericel (VCEL) does not offer dividends to its shareholders. Investors interested in Vericel should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Vericel?
Some of the similar stocks of Vericel are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.